Ovarian Suppression for Breast Cancer: An Effective Treatment in Search of a Home

This publication has 20 references indexed in Scilit:

• Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188)
  Journal of Clinical Oncology, 2005
• American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004
  Journal of Clinical Oncology, 2005
• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
  New England Journal of Medicine, 2004
• Adjuvant Chemotherapy Followed by Goserelin Versus Either Modality Alone for Premenopausal Lymph Node-Negative Breast Cancer: A Randomized Trial
  JNCI Journal of the National Cancer Institute, 2003
• Repeated observation of breast tumor subtypes in independent gene expression data sets
  Proceedings of the National Academy of Sciences, 2003
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  Proceedings of the National Academy of Sciences, 2001
• Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
  The Lancet, 2000
• Ovarian ablation in early breast cancer: overview of the randomised trials
  The Lancet, 1996
• Age as prognostic factor in premenopausal breast carcinoma
  The Lancet, 1993
• The Relation between Survival and Age at Diagnosis in Breast Cancer
  New England Journal of Medicine, 1986